LRRK2 and colitis: Other studies in LRRK2 KO animals suggest that LRRK2 is a modulator of toxic insults, including a modulator of experimental colitis [34], susceptibility to carcinogen-induced lung cancer [35], and sensitivity to alpha-synuclein mediated nigrostriatal neurodegeneration [36].